Avacta plc is a biotechnology and engineering company shaping the future of medicine by developing safe and effective drugs for a wide range of life sciences applications (research and diagnostics). The company specialises in the production of affimers as an alternative to synthetic antibodies.
Avacta
- Company type
- Biotechnology spin out